SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-092257
Filing Date
2024-08-07
Accepted
2024-08-07 06:45:21
Documents
63
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycn-20240630.htm   iXBRL 10-Q 1427562
2 EX-10.1 cycn-ex10_1.htm EX-10.1 63168
3 EX-31.1 cycn-ex31_1.htm EX-31.1 11789
4 EX-31.2 cycn-ex31_2.htm EX-31.2 11792
5 EX-32.1 cycn-ex32_1.htm EX-32.1 6343
6 EX-32.2 cycn-ex32_2.htm EX-32.2 6346
  Complete submission text file 0000950170-24-092257.txt   6391238

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cycn-20240630.xsd EX-101.SCH 1074674
65 EXTRACTED XBRL INSTANCE DOCUMENT cycn-20240630_htm.xml XML 1046982
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 241181335
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)